Immunotherapeutic Approaches for Alzheimer’s Disease

Cited by (284)

Items 101–200 of 284

1. Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases
   Falguni Baidya, Mariya Bohra, Aishika Datta, Deepaneeta Sarmah, Birva Shah, Priya Jagtap, Swapnil Raut, Ankan Sarkar, Upasna Singh, Kiran Kalia et al. · 2020 · Immunology
2. Towards Personalized Intervention for Alzheimer’s Disease
   Xing Peng, Peiqi Xing, Xiuhui Li, Ying Qian, Fuhai Song, Zhouxian Bai, Guangchun Han, Hongxing Lei · 2016 · Genomics Proteomics & Bioinformatics
3. Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice
   Chun Teng Zhang, Jingran Lin, Feng Wu, Arijit Ghosh, Su Su Tang, Mei Ying Hu, Yan Long, Hong Sun, Hao Hong · 2016 · NeuroToxicology
4. New drugs in psychiatry: focus on new pharmacological targets
   Filippo Caraci, Gian Marco Leggio, Salvatore Salomone, Filippo Drago · 2017 · F1000Research
5. Europium-Doped Cerium Oxide Nanoparticles for Microglial Amyloid Beta Clearance and Homeostasis
   Jatin Machhi, Pravin Yeapuri, Milica Marković, Milankumar Patel, Wenhui Yan, Yaman Lu, Jacob D. Cohen, Mahmudul Hasan, Mai Mohamed Abdelmoaty, You Zhou et al. · 2022 · ACS Chemical Neuroscience
6. Alzheimers Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease
   Cinzia Severini, Christian Barbato, Maria Grazia Di Certo, Francesca Gabanella, Carla Petrella, Arianna Di Stadio, Marco DE VINCENTIIS, Antonella Polimeni, Massimo Ralli, Antonio Greco · 2020 · Current Neuropharmacology
7. Active Vaccines for Alzheimer Disease Treatment
   Rosalie M. Sterner, Paul Y. Takahashi, Aimee Yu Ballard · 2016 · Journal of the American Medical Directors Association
8. Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia
   Boris Decourt, Keith Noorda, Kevin J. Noorda, Jiong Shi, Marwan Noel Sabbagh · 2022 · Journal of Experimental Pharmacology
9. Neurochemical and neuroinflammatory perturbations in two Gulf War Illness models: Modulation by the immunotherapeutic LNFPIII
   Jessica M. Carpenter, H.E. Gordon, Helaina Danielle Ludwig, John J. Wagner, Donald A. Harn, Thomas Norberg, Nikolay M. Filipov · 2019 · NeuroToxicology
10. Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer’s Disease Mouse Model
    Jiuyang Ding, Jian V. Huang, Dan Yin, Ting Liu, Zheng Ren, Shanshan Hu, Cuiyun Le, Cuiyun Le, Hongmei Zhou, Li Zhu et al. · 2021 · Oxidative Medicine and Cellular Longevity
11. Aberrant expression of the pore-forming KATP channel subunit Kir6.2 in hippocampal reactive astrocytes in the 3xTg-AD mouse model and human Alzheimer's disease.
    Chelsea M. Griffith, M. Xie, Wen-Ying Qiu, Andrew A. Sharp, Chao Ma, A. Pan, Xiao-Mei Yan, P. Patrylo · 2016 · Neuroscience
12. Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease
    Allal Boutajangout, Abdulwahab A. Noorwali, Hazem Mahmoud Atta, Thomas Wısnıewskı · 2016 · Current Alzheimer Research
13. Neurologic Complications of Human Immunodeficiency Virus Infection
    Avindra Nath · 2015 · CONTINUUM Lifelong Learning in Neurology
14. Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson’s disease
    Ramesh Duwa, Jee‐Heon Jeong, Simmyung Yook · 2021 · Journal of Pharmaceutical Investigation
15. Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing
    Akbar Hasanzadeh, Hamid Noori, Atefeh Jahandideh, Niloofar Haeri Moghaddam, Seyede Mahtab Kamrani Mousavi, Helena Nourizadeh, Sara Saeedi, Mahdi Karimi, Michael Richard Hamblin · 2022 · ACS Applied Bio Materials
16. Alzheimer’s Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches
    Udo Rüb, Katharina Stratmann, Helmut Heinsen, Kay Seidel, Mohamed Bouzrou, Horst‐Werner Korf · 2017 · Journal of Alzheimer s Disease
17. Autophagy is involved in oral rAAV/Aβ vaccine-induced Aβ clearance in APP/PS1 transgenic mice
    He-Cheng Wang, Tao Zhang, Bolati Kuerban, Ying-Lan Jin, Weidong Le, Hideo Hara, Dong-Sheng Fan, Yan‐Jiang Wang, Takeshi Tabira, De-Hua Chui · 2015 · Neuroscience Bulletin
18. Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies
    Todd Eliot Golde · 2016 · Journal of Neurochemistry
19. [Gly14]-Humanin Protects Against Amyloid β Peptide-Induced Impairment of Spatial Learning and Memory in Rats
    Yuan Li, Xiaojie Liu, Wei-Na Han, Qingshan Li, Zhao‐Jun Wang, Meina Wu, Wei Yang, Jin‐Shun Qi · 2016 · Neuroscience Bulletin
20. Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
    Ning Shen, Ge Song, Haiqiang Yang, Xiaoyang Lin, Breanna Brown, Yuzhu Hong, Jianfeng Cai, Chuanhai Cao · 2019 · International Journal of Molecular Sciences
21. The Role of Synaptic Dysfunction in Alzheimer’s Disease
    Yixuan Amy Pei, Julie Davies, Melanie Zhang, Han‐Ting Zhang · 2020 · Journal of Alzheimer s Disease
22. The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation
    Weiguo Dong, Christine M. Embury, Yaman Lu, Sarah M. Whitmire, Bhagyalaxmi Dyavarshetty, Harris A. Gelbard, Howard Eliot Gendelman, Tomomi Kiyota · 2016 · Journal of Neuroinflammation
23. Long-Term DL-3-n-Butylphthalide Treatment Alleviates Cognitive Impairment Correlate With Improving Synaptic Plasticity in SAMP8 Mice
    Chaonan Lv, Qinying Ma, Bing Han, Jing Li, Yuan Geng, Xiaoman Zhang, Mingwei Wang · 2018 · Frontiers in Aging Neuroscience
24. In Situ Monitoring the Aggregation Dynamics of Amyloid-β Protein Aβ42 in Physiological Media via a Raman-Based Frequency Shift Method
    Wenfeng Zhu, Yibing Wang, Dan Xie, Linxiu Cheng, Ping Wang, Qingdao Zeng, Min Li, Yuliang Zhao · 2018 · ACS Applied Bio Materials
25. YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
    Xiaowan Wang, Runmin Song, Wenliang Lu, Ziyu Liu, Lichun Wang, Xiaojuan Zhu, Yanjun Liu, Zijie Sun, Jiang Li, Xiaomeng Li · 2017 · Frontiers in Aging Neuroscience
26. Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease
    Eleanor Drummond, Fernando Goñi, Shan Liu, Frances Prelli, Henrieta Scholtzova, Thomas Wısnıewskı · 2018 · Journal of Alzheimer s Disease
27. Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings
    Pallavi Duggal, Sidharth Mehan · 2019 · Journal of Alzheimer s Disease Reports
28. Label-Free Analysis of Protein Biomarkers Using Pattern-Optimized Graphene-Nanopyramid SERS for the Rapid Diagnosis of Alzheimer’s Disease
    He‐Ping Wu, Yan Duan, Luyue Jiang, Xinhao Cao, Zhen Xie, Yi Quan, Matthew Xinhu Ren, Shengli Wu, Nan Zhang, Zhugen Yang et al. · 2024 · ACS Applied Nano Materials
29. Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
    Vyronia Vassilakopoulou, Chrysoula‐Evangelia Karachaliou, Alexandra Evangelou, Christos C. Zikos, Evangelia Livaniou · 2021 · Vaccines
30. Peptidylarginine Deiminase and Alzheimer’s Disease
    Lai Wang, Hongyang Chen, Jing Tang, Zhengwei Guo, Yanming Wang · 2021 · Journal of Alzheimer s Disease
31. Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages
    Paulina R. Davis, Ginevra Giannini, Karin Rudolph, Nathaniel T. Calloway, Christopher M. Royer, Tina L. Beckett, M. Paul Murphy, Frederick Bresch, Dieter Pagani, Thomas L Platt et al. · 2016 · Neurobiology of Aging
32. Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases
    Yoshiki Takamatsu, Gilbert J. Ho, Wakako Koike, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Jianshe Wei, Kazunari Sekiyama, Makoto Hashimoto · 2017 · npj Parkinson s Disease
33. Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's
    Nikita Subhash Hinge, Himanshu Kathuria, Murali Monohar Pandey · 2021 · Applied Materials Today
34. Cerebral Glucose Metabolism Assessment in Rat Models of Alzheimer’s Disease
    Yangjia Lu, Jie Ren, Shaoyang Cui, Junqi Chen, Yong Huang, Chunzhi Tang, Baoci Shan, Binbin Nie, Lai Xinsheng · 2015 · American Journal of Alzheimer s Disease & Other Dementias®
35. Desipramine improves depression-like behavior and working memory by up-regulating p-CREB in Alzheimer’s disease associated mice
    Dandan Wang, Jia Li, Li-Peng Yu, Meina Wu, Lina Sun, Jin‐Shun Qi · 2016 · Journal of Integrative Neuroscience
36. “Tau immunotherapy: Hopes and hindrances”
    Koorosh Shahpasand, Alireza Sepehri Shamloo, Seyed Massood Nabavi, Kun Ping Lu, Xiao Zhen Zhou · 2017 · Human Vaccines & Immunotherapeutics
37. Toward a New Concept of Alzheimer’s Disease Models: A Perspective from Neuroinflammation
    Antonia Gutiérrez, Javier Vitórica · 2018 · Journal of Alzheimer s Disease
38. Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
    Allal Boutajangout, Hanna Lindberg, Abdulaziz Awwad, Arun Paul, Rabaa Baitalmal, Ismail K. Almokyad, Ingmarie Höidén‐Guthenberg, Elin Gunneriusson, Fredrik Y. Frejd, Torleif Härd et al. · 2019 · Frontiers in Aging Neuroscience
39. Alzheimer’s Disease Immunotherapy: Current Strategies and Future Prospects
    Ali Aljassabi, Tarek Zieneldien, Janice Kim, Deepika Regmi, Chuanhai Cao · 2024 · Journal of Alzheimer s Disease
40. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
    Krystal Herline, Frances Prelli, Pankaj D Mehta, Claire MacMurray, Fernando Goñi, Thomas Wısnıewskı · 2018 · Alzheimer s Research & Therapy
41. Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer’s Disease
    Norimichi Nakamura, Yasumasa Ohyagi, Tomohiro Imamura, Yuki T. Yanagihara, Kyoko Iinuma, Naoko Soejima, Hiroyuki Murai, Ryo Yamasaki, Jun‐ichi Kira · 2017 · Journal of Alzheimer s Disease
42. A Review on Mitochondrial Derived Peptide Humanin and Small Humanin-Like Peptides and Their Therapeutic Strategies
    H. Thamarai Kannan, Praveen Kumar Issac, Nibedita Dey, Ajay Guru, Jesu Arockiaraj · 2023 · International Journal of Peptide Research and Therapeutics
43. Re-evaluation of the Blood-Brain Barrier in the Presence of Alzheimer’s Disease Pathology
    Jason D. Ulrich, Tien‐Phat V. Huynh, David M. Holtzman · 2015 · Neuron
44. Recapitulating Amyloid ß and Tau Pathology in Human Neural Cell Culture Models—Clinical Implications
    Se Hoon Choi, Young Hye Kim, Carla D’Avanzo, Jenna Aronson, Rudolph E. Tanzi, Doo Yeon Kim, Postdoc Associate, Professor · 2015 · touchREVIEWS in Neurology
45. Acute Effects of Focused Ultrasound-Induced Blood-Brain Barrier Opening on Anti-Pyroglu3 Abeta Antibody Delivery and Immune Responses
    Praveen Bathini, Tao Sun, Mathias Schenk, Stephan Schilling, Nathan Judson McDannold, Cynthia Ann Lemere · 2022 · Biomolecules
46. Blood-Based Biomarkers of Alzheimers Disease: Diagnostic Algorithms and New Technologies
    P. Carmona, Marina Molina, A. Tolédano · 2016 · Current Alzheimer Research
47. Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease
    Kanchana K. Gamage, Sushanth Kumar · 2017 · Journal of Neuroscience
48. In vivo detection of amyloid plaques by gadolinium-stained MRI can be used to demonstrate the efficacy of an anti-amyloid immunotherapy.
    Santin, Mathieu D., Vandenberghe, Michel E., Herard, Anne-Sophie, Pradier, Laurent, Cohen, Caroline, Debeir, Thomas, Delzescaux, Thierry, Rooney, Thomas, Dhenain, Marc · 2016 · Frontiers in Aging Neuroscience
49. Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer’s disease
    Lu Fu, Yingnan Li, Yue Hu, Yayuan Zheng, Bin Yu, Haihong Zhang, Jiaxin Wu, Hui Wu, Xianghui Yu, Wei Kong · 2017 · Scientific Reports
50. Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
    Fernando Goñi, Mitchell Martá-Ariza, Krystal Herline, Daniel Kevin Peyser, Allal Boutajangout, Pankaj D Mehta, Eleanor Drummond, Frances C. Prelli, Thomas Wısnıewskı · 2018 · Alzheimer s Research & Therapy
51. Future horizons in Alzheimer's disease research
    Thomas Wısnıewskı, Eleanor Drummond · 2019 · Progress in molecular biology and translational science
52. Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease
    Stefan Bartl, Abid Oueslati, Amber L. Southwell, Alberto Siddu, Michela Parth, Linda Suzanne David, Alexander Maxan, Nina Salhat, Markus Burkert, Andreas Mairhofer et al. · 2020 · Neurobiology of Disease
53. Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
    Caraci, Filippo, Iulita, M. Florencia, Pentz, Rowan, Flores Aguilar, Lisi, Orciani, Chiara, Barone, Concetta, Romano, Corrado, Drago, Filippo, Cuello, A. Claudio · 2017 · European Journal of Pharmacology
54. Evaluation of Peripheral Immune Dysregulation in Alzheimer’s Disease and Vascular Dementia
    Zongjun Guo, Xing Peng, Hui-Yun Li, Yunlai Wang, Ying Qian, Zhihong Wang, Dong‐Qing Ye, Xiaoyun Ji, Zhixin Wang, Yan‐Jiang Wang et al. · 2019 · Journal of Alzheimer s Disease
55. Norovirus P particle: An excellent vaccine platform for antibody production against Alzheimer’s disease
    Lu Fu, Yingnan Li, Yue Hu, Bin Yu, Haihong Zhang, Jiaxin Wu, Hui Wu, Xianghui Yu, Wei Kong · 2015 · Immunology Letters
56. Immunotherapy in Alzheimer’s disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline
    Ali Azargoonjahromi · 2024 · Journal of Pharmacy and Pharmacology
57. Steroid sulfatase inhibitor DU-14 protects spatial memory and synaptic plasticity from disruption by amyloid β protein in male rats
    Xing-Hua Yue, Jia‐Qing Tong, Zhao‐Jun Wang, Jun Zhang, Xu Liu, Xiaojie Liu, Hong-Yan Cai, Jin‐Shun Qi · 2016 · Hormones and Behavior
58. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases
    Jia Zhao, Mengxia Zhu, Mukesh Kumar, Fung Yin Ngo, Yinghui Li, Lixing Lao, Jianhui Rong · 2018 · CNS & Neurological Disorders - Drug Targets
59. Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)
    Pramod N. Nehete, Lawrence E. Williams, Sriram Chitta, Bharti P. Nehete, Akash G. Patel, Margish D. Ramani, Thomas Wısnıewskı, Henrieta Scholtzova · 2020 · Frontiers in Aging Neuroscience
60. Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases
    Fernando Goñi, Mitchell Martá-Ariza, Daniel Kevin Peyser, Krystal Herline, Thomas Wısnıewskı · 2017 · Scientific Reports
61. Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations
    Jeremy J. Kudrna, Kenneth E. Ugen · 2015 · Human Vaccines & Immunotherapeutics
62. Drugs for Targeted Therapies of Alzheimer’s Disease
    Chit Tam, Jack Ho Wong, Tzi Bun Ng, Stephen Kwok‐Wing Tsui, Tao Zuo · 2018 · Current Medicinal Chemistry
63. Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer’s Disease
    Lenka Hromádková, Saak Victor Ovsepian · 2019 · Journal of Immunology Research
64. Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for Alzheimer’s Disease
    Deborah Doens, Mario E. Valdés‐Tresanco, Velmarini Vasquez, María B. Carreira, Yila de la Guardia, David E. Stephens, Viet D. Nguyen, Vu T. Nguyen, Jianhua Gu, Muralidhar L. Hegde et al. · 2019 · ACS Chemical Neuroscience
65. Immunotherapeutic approaches for Alzheimer’s disease: Exploring active and passive vaccine progress
    Bhadane, Priyanshu, Roul, Krishnashish, Belemkar, Sateesh, Kumar, Devendra · 2024 · Brain Research
66. Designing nanodiscs as versatile platforms for on-demand therapy
    Qianwen Mu, Haolan Deng, Xiaoyu An, Gang Liu, Chao Liu · 2023 · Nanoscale
67. Comparison of the amyloid plaque proteome in Down syndrome, early‐onset Alzheimer's disease, and late‐onset Alzheimer's disease
    Martá-Ariza, Mitchell, Leitner, Dominique F., Kanshin, Evgeny, Suazo, Jianina, Giusti Pedrosa, Ana, Thierry, Manon, Lee, Edward B., Devinsky, Orrin, Drummond, Eleanor, Fortea, Juan et al. · 2025 · Acta Neuropathologica
68. Spreading of Pathology in Alzheimer’s Disease
    Zhongyue Lv, Chen‐Chen Tan, Jin‐Tai Yu, Lan Tan · 2017 · Neurotoxicity Research
69. Aspects of the immune system that impact brain function
    Stephen Claude Bondy · 2020 · Journal of Neuroimmunology
70. Use of lecanemab for the treatment of Alzheimer's disease: A systematic review
    Md Fahad Hossain, Ashma Ul Husna, Manish Kharel · 2024 · Brain and Behavior
71. Emerging paradigms in Alzheimer's therapy
    Agnes Preethy H., Kayalvizhi Rajendran, Anitha Josephine Sukumar, Uma Maheswari Krishnan · 2024 · European Journal of Pharmacology
72. Immunotherapy in Alzheimer’s Disease: Current Status and Future Directions
    Kshitij Vashisth, Shivani Sharma, Shampa Ghosh, Marianesan Arockia Babu, Soumya Ghosh, Danish Iqbal, Mehnaz Kamal, Abdulmajeed G. Almutary, Saurabh Kumar Jha, Shreesh Kumar Ojha et al. · 2024 · Journal of Alzheimer s Disease
73. Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates
    Armine Hovakimyan, Karen Zagorski, Gor Chailyan, Tatevik Antonyan, Levon Melikyan, Irina Petrushina, Dash G. Batt, Olga King, Manush Ghazaryan, A Donthi et al. · 2022 · npj Vaccines
74. Update on the role of T cells in cognitive impairment
    Ignacio Ruiz‐Fernández, Raquel Sánchez‐Díaz, Enrique Ortega‐Sollero, Pilar Martı́n · 2023 · British Journal of Pharmacology
75. Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers
    Éva Bartus, Gábor Olajos, Ildikó Schuster, Zsolt Bozsó, Mária A. Deli, Szilvia Veszelka, Fruzsina R. Walter, Zsolt Datki, Zsolt Szakonyi, Tamás A. Martinek et al. · 2018 · Molecules
76. Preparation and in vitro activity of single chain antibodies against Alzheimer's disease
    Lu Fu, Yu Zhang, Xu Zhang, Wenhan Tian, Wenhui Zhang, Yu Xiang Jia, Linbo Zhang · 2020 · Immunology Letters
77. Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease
    Maxime Gagnon, Martin Savard, Thi Minh Hue Tran, Laurence Vincent, Alexandre Moquin, Philippe Tremblay, Xavier Roucou, Yves L. Dory, Fernand Gobeil · 2023 · Molecules
78. Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease
    Sha Sha, Lina Ren, Xiaona Xing, Wanshu Guo, Yan Wang, Ying Li, Yunpeng Cao, Le Qu · 2025 · Neural Regeneration Research
79. Organoplatinum‐Substituted Polyoxometalate Inhibits β‐amyloid Aggregation for Alzheimer's Therapy
    Jing Wei Zhao, Kexin Li, Kaiwei Wan, Tiedong Sun, Nannan Zheng, Fanjiao Zhu, Jichao Ma, Jia Jiao, Tianchan Li, Jinyuan Ni et al. · 2019 · Angewandte Chemie
80. Molecular characterization of the β ‐amyloid(4‐10) epitope of plaque specific Aβ antibodies by affinity‐mass spectrometry using alanine site mutation
    Raluca Ştefănescu, Loredana Lupu, Marilena Manea, Roxana E. Iacob, Michael Przybylski · 2018 · Journal of Peptide Science
81. DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
    Sha Sha, Xiao-Na Xing, Tao Wang, Ying Li, Rongwei Zhang, Xueli Shen, Yunpeng Cao, Le Qu · 2022 · Neural Regeneration Research
82. Potential roles of brain barrier dysfunctions in the early stage of Alzheimer’s disease
    Wenxuan Jian, Zhao Zhang, Shifeng Chu, Ye Peng, Nai‐Hong Chen · 2018 · Brain Research Bulletin
83. Exploring new avenues for modifying course of progression of Alzheimer's disease: The rise of natural medicine
    Sarah Lye, Caitlin E. Aust, Lyn Robyn Griffiths, Francesca Fernandez · 2021 · Journal of the Neurological Sciences
84. Emerging Materials, Wearables, and Diagnostic Advancements in Therapeutic Treatment of Brain Diseases
    Brindha Ramasubramanian, Vundrala Sumedha Reddy, Vijila Chellappan, Seeram Ramakrishna · 2022 · Biosensors
85. Anti-Amyloid-β Immunotherapy for Alzheimer’s Disease
    Helen Crehan, Cynthia Ann Lemere · 2016 · Elsevier eBooks
86. A Modification-Specific Peptide-Based immunization Approach Using CRM197 Carrier Protein: Development of a Selective Vaccine Against Pyroglutamate Aβ Peptides
    Valérie Vingtdeux, Haitian Zhao, Pallavi Chandakkar, Christopher M. Acker, Peter Davies, Philippe Marambaud · 2016 · Molecular Medicine
87. A novel antibody targeting sequence 31–35 in amyloid β protein attenuates Alzheimer's disease‐related neuronal damage
    Li Cheng, Jun Zhang, Xinyi Li, Yuan Li, Yanfang Pan, Xiaorong Chen, Tianming Gao, Jian‐Tian Qiao, Jin‐Shun Qi · 2016 · Hippocampus
88. Naturally-Occurring Antibodies Against Bim are Decreased in Alzheimer’s Disease and Attenuate AD-type Pathology in a Mouse Model
    Jie-Ming Jian, Dong‐Yu Fan, Ding‐Yuan Tian, Yuan Cheng, Pu‐Yang Sun, Cheng‐Rong Tan, Gui‐Hua Zeng, Chen-Yang He, Ye‐Ran Wang, Jie Zhu et al. · 2022 · Neuroscience Bulletin
89. TNAP upregulation is a critical factor in Tauopathies and its blockade ameliorates neurotoxicity and increases life-expectancy
    Álvaro Sebastián‐Serrano, Jesús Merchán‐Rubira, Caterina Di Lauro, Carolina Bianchi, Lucía Soria-Tobar, Sonoko Narisawa, José Luís Millán, Jesús Ávila, Félix Hernández, Miguel Dı́az-Hernández · 2022 · Neurobiology of Disease
90. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β 3-42 (pE 3 -Aβ)
    Pankaj D Mehta, Bruce A. Patrick, Marc Barshatzky, Sangita P. Mehta, Janusz Frackowiak, Bozena Mazur‐Kolecka, Jerzy Węgiel, Thomas Wısnıewskı, David L. Miller · 2018 · Journal of Alzheimer s Disease
91. Follow-up of active Aβ immunization in Alzheimer disease
    Thomas Wısnıewskı · 2019 · Nature Reviews Neurology
92. Amyloid-Directed Antibodies: Past, Present, and Future
    Keith Noorda, Kevin J. Noorda, Marwan N. Sabbagh, John A. Bertelson, Jonathan Singer, Boris Decourt · 2024 · Journal of Alzheimer s Disease
93. Versatile lipoprotein-inspired nanocomposites rescue Alzheimer's cognitive dysfunction by promoting Aβ degradation and lessening oxidative stress
    Hui Wang, Mengmeng Han, Jianfei Li, Yunfeng Hu, Yang Chen, Jin Li · 2023 · Nanoscale
94. Targeting Microglial Immunoproteasome: A Novel Approach in Neuroinflammatory-Related Disorders
    Natalia Małek, Radoslaw Gladysz, Natalia Stelmach, Marcin Drąg · 2024 · ACS Chemical Neuroscience
95. PROTACs and Other Chemical Protein Degradation Technologies for the Treatment of Neurodegenerative Disorders
    Shusuke Tomoshige, Minoru Ishikawa · 2020 · Angewandte Chemie
96. Tacrine Induces Endoplasmic Reticulum–Stressed Apoptosis via Disrupting the Proper Assembly of Oligomeric Acetylcholinesterase in Cultured Neuronal Cells
    Etta Y.L. Liu, Shinghung Mak, Xiangpeng Kong, Yingjie Xia, Kenneth Kin‐Leung Kwan, Miranda Li Xu, Karl Wah Keung Tsim · 2021 · Molecular Pharmacology
97. RETRACTED: Improvement of extraction from Hericium erinaceus on the gut-brain axis in AD-like mice
    Xiangxiang Zhu, Zilei Zhang, Xin Yang, Longkai Qi, Yinrui Guo, Xiaocui Tang, Yizhen Xie, Diling Chen · 2022 · Brain Research · Retracted
98. Current study on diagnosis and treatment of Alzheimer’s disease by targeting amyloid b-protein
    Kai-Ye Hua, Weijiang Zhao · 2022 · Folia Neuropathologica
99. Alzheimers Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease
    Cinzia Severini · 2021 · Current Neuropharmacology
100. Mechanismen der Alzheimer-Krankheit
     Marc Aurel Busche, Mathias Staufenbiel, Michael Willem, Christian Haass, Hans Förstl · 2016 · Der Nervenarzt